Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Nov 14, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PTC | PTC INC | NASDAQ | Software - Application | A | $20.91B | $174.57 | -2.02% | $885.58M | 40.98x | 0.77 | United States | 46 |
| TPR | TAPESTRY INC | NYSE | Luxury Goods | A | $20.62B | $100.76 | -3.10% | $598.20M | 74.09x | 14.93 | United States | 36 |
| NBIX | NEUROCRINE BIOSCIENCES INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $14.37B | $144.17 | -1.83% | $679.20M | 33.45x | 0.42 | United States | 52 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | A | $8.61B | $141.71 | 3.66% | $182.64M | -23.66x | 1.87 | Ireland | 16 |
| PRIM | PRIMORIS SERVICES CORP | NYSE | Engineering & Construction | A | $6.29B | $116.43 | -5.37% | $513.21M | 22.70x | 1.86 | United States | 54 |
| SGHC | SUPER GROUP (SGHC) LTD | NYSE | Gambling | A | $6.22B | $12.30 | -3.38% | N/A | 24.70x | 0.60 | Guernsey | 32 |
| GTES | GATES INDUSTRIAL CORP PLC | NYSE | Specialty Industrial Machinery | A | $5.80B | $22.47 | -1.06% | $672.10M | 24.42x | 1.02 | United States | 37 |
| RSI | RUSH STREET INTERACTIVE INC | NYSE | Gambling | A | $3.98B | $17.35 | -0.06% | -$33.04M | 52.58x | 2.40 | United States | 50 |
| MIRM | MIRUM PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $3.56B | $69.25 | -2.16% | -$592.00k | -81.47x | 1.69 | United States | 26 |
| TPC | TUTOR PERINI CORP | NYSE | Engineering & Construction | A | $3.15B | $59.64 | -4.24% | $108.27M | -110.44x | 3.28 | United States | 28 |
| FOLD | AMICUS THERAPEUTICS INC | NASDAQ | Biotechnology | A | $2.89B | $9.38 | -0.42% | $59.28M | -234.50x | 2.77 | United States | 23 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $2.55B | $44.44 | -0.40% | $64.66M | -134.67x | 0.35 | United States | 28 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.38B | $183.77 | -2.99% | $301.16M | 10.65x | 1.82 | United States | 50 |
| SPNT | SIRIUSPOINT LTD | NYSE | Insurance - Reinsurance | A | $2.34B | $20.07 | -0.99% | $339.10M | 12.09x | 4.64 | Bermuda | 30 |
| IHS | IHS HOLDING LTD | NYSE | Telecom Services | A | $2.16B | $6.43 | -6.54% | N/A | 4.59x | -34.21 | United Kingdom | 30 |
| PGY | PAGAYA TECHNOLOGIES LTD | NASDAQ | Software - Infrastructure | A | $1.93B | $23.40 | -9.72% | -$155.79M | -8.54x | 2.03 | Israel | 21 |
| BLBD | BLUE BIRD CORP | NASDAQ | Auto Manufacturers | A | $1.65B | $51.90 | 0.56% | $175.74M | 14.30x | 1.59 | United States | 46 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $1.45B | $6.90 | -3.90% | $83.87M | -138.00x | -2.15 | United States | 17 |
| CRTO | CRITEO SA | NASDAQ | Advertising Agencies | A | $1.13B | $21.55 | -5.65% | $219.28M | 6.91x | 0.79 | France | 51 |
| ANAB | ANAPTYSBIO INC | NASDAQ | Biotechnology | A | $920.92M | $33.26 | 0.51% | -$82.14M | -12.14x | -13.00 | United States | 15 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $788.12M | $6.21 | -4.17% | $18.04M | -51.75x | 0.49 | United States | 21 |
| UDMY | UDEMY INC | NASDAQ | Education & Training Services | A | $762.62M | $5.21 | -1.88% | $28.86M | -173.67x | 1.79 | United States | 23 |
| BWMN | BOWMAN CONSULTING GROUP LTD | NASDAQ | Engineering & Construction | A | $593.47M | $34.16 | -2.34% | $38.00M | 34.86x | 0.95 | United States | 53 |
| AKBA | AKEBIA THERAPEUTICS INC | NASDAQ | Biotechnology | A | $467.04M | $1.76 | -4.86% | $25.70M | -22.00x | 7.76 | United States | 25 |
| OPRX | OPTIMIZERX CORP | NASDAQ | Health Information Services | A | $288.18M | $15.46 | -4.27% | $11.65M | N/A | 0.39 | United States | 29 |
| EGHT | 8X8 INC | NASDAQ | Software - Application | A | $273.12M | $1.97 | -3.43% | $51.06M | -49.25x | 4.04 | United States | 16 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $220.00M | $26.35 | 3.82% | $11.32M | 29.61x | 0.25 | United States | 51 |
| CXDO | CREXENDO INC | NASDAQ | Telecom Services | A | $208.36M | $6.78 | -8.25% | $7.94M | 45.20x | 0.24 | United States | 42 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $206.62M | $10.16 | -2.59% | $24.16M | 39.08x | 0.78 | United States | 42 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.